Stock listing
OTC:BLCM Bellicum Pharmaceuticals Inc Stock
Follow Bellicum Pharmaceuticals Inc into a list and get an email when it puts out news.
Delisted OTC:BLCM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- OTC:BLCM
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Bellicum Pharmaceuticals Inc on 6ix
- Decks
- 9 decks · latest Dec 6, 2021
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2021) | Investor deck | 28 slides | Dec 6, 2021 |
| Investor Presentation (September 2021) | Investor deck | 28 slides | Sep 13, 2021 |
| Investor Presentation (February 2021) | Investor deck | 25 slides | Feb 9, 2021 |
| Investor Presentation (October 2020) | Investor deck | 26 slides | Oct 29, 2020 |
| Investor Presentation (January 2020) | Investor deck | 29 slides | Jan 15, 2020 |
| Investor Presentation (July 2019) | Investor deck | 29 slides | Jul 29, 2019 |
| Investor Presentation (June 2019) | Investor deck | 31 slides | Jun 4, 2019 |
| Investor Presentation (June 2019) | Investor deck | 30 slides | Jun 3, 2019 |
| Investor Presentation (March 2019) | Investor deck | 33 slides | Mar 13, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Atabak Mokari Other companies: Corcept Therapeutics Incorporated (Chief Financial Officer · Since at least Mar 1, 2021); IRIDEX Corporation (CFO and VP Corp Development · Jul 11, 2016 – Nov 24, 2018 · Past) | Chief Financial Officer · Dec 19, 2018 – Apr 8, 2020 · Past |
| Richard A Fair Other companies: Enliven Therapeutics, Inc. (PRESIDENT AND CEO, Director · Since at least Dec 11, 2025); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past) | President and CEO, Director · Jan 30, 2017 – Aug 15, 2022 · Past |
| Ken Moseley Other companies: Marker Therapeutics, Inc. (General Counsel · Dec 21, 2018 – Dec 21, 2018 · Past) | Sr. VP and General Counsel · Dec 17, 2014 – Jan 3, 2018 · Past |
| Charles S Grass | Principal Accounting Officer · May 11, 2021 – May 11, 2021 · Past |
| Frank B McGuyer | Director · Jun 15, 2016 – Jun 14, 2018 · Past |
Log in to ask 6ix AI your own questions about Bellicum Pharmaceuticals Inc.